NCT04446416 2023-09-06Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM PatientsNaviFUS CorporationPhase NA Completed6 enrolled
NCT01125943 2013-01-10Bevacizumab and Endothelium Dependent VasodilationRadboud University Medical CenterPhase NA Completed24 enrolled